Pharmacological blockade of Kv1.3 showed a strong therapeutic effect on RA model animals, suggesting that Kv1.3 is a new target for the discovery of specific RA immunosuppressive drugs (16, 17). This evidence concerns the gene KCNA3 and rheumatoid arthritis.